# Flotek Industries Inc: Form 10-Q for the period ended Sep 30, 2019

- Company: [Flotek Industries Inc](/companies/ftk.md) (CIK 928054)
- Form: 10-Q
- Filed: 2019-11-12
- Accepted by EDGAR: Nov 12, 2019, 16:51 ET
- Period: 2019-09-30
- Accession: 0000928054-19-000095
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/928054/000092805419000095/ftk2019093010q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/928054/000092805419000095/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2019-09-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2019-07-01 to 2019-09-30 | $21.9m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-01-01 to 2019-09-30 | $99.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2019-07-01 to 2019-09-30 | $23.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-01-01 to 2019-09-30 | $106.6m | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 3 months, 2019-07-01 to 2019-09-30 | $2.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months, 2019-01-01 to 2019-09-30 | $6.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2019-07-01 to 2019-09-30 | −$11.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-01-01 to 2019-09-30 | −$40.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2019-07-01 to 2019-09-30 | $1.0k | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-01-01 to 2019-09-30 | $2.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2019-07-01 to 2019-09-30 | −$191.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-01-01 to 2019-09-30 | −$1.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2019-07-01 to 2019-09-30 | −$11.1m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-01-01 to 2019-09-30 | $7.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2019-07-01 to 2019-09-30 | −$0.19 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-01-01 to 2019-09-30 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2019-07-01 to 2019-09-30 | −$0.19 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-01-01 to 2019-09-30 | $0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2019-07-01 to 2019-09-30 | 59,004,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-01-01 to 2019-09-30 | 58,725,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 9 months, 2019-01-01 to 2019-09-30 | $1.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2019-09-30 | $107.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2019-09-30 | $166.5m | us-gaap:AssetsCurrent |
| Total assets | at 2019-09-30 | $249.4m | us-gaap:Assets |
| Current liabilities | at 2019-09-30 | $19.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2019-09-30 | $37.6m | us-gaap:Liabilities |
| Current portion of debt | at 2019-09-30 | $0 | us-gaap:LongTermDebtCurrent |

## Management's discussion and analysis

As filed, 35,489 characters.

### Forward-Looking Statements

This Quarterly Report on Form 10-Q (“Quarterly Report”), and in particular, Part I, Item 2 — “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains “forward-looking statements” within the meaning of the safe harbor provisions, 15 U.S.C. § 78u-5, of the Private Securities Litigation Reform Act of 1995 (“Reform Act”). Forward-looking statements are not historical facts, but instead represent Flotek Industries, Inc.’s (“Flotek” or “Company”) current assumptions and beliefs regarding future events, many of which, by their nature, are inherently uncertain and outside the Company’s control. Such statements include estimates, projections, and statements related to the Company’s business plan, objectives, expected operating results, and assumptions upon which those statements are based. The forward-looking statements contained in this Quarterly Report are based on information available as of the date of this Quarterly Report.

The forward-looking statements relate to future industry trends and economic conditions, forecast performance or results of current and future initiatives and the outcome of contingencies and other uncertainties that may have a significant impact on the Company’s business, future operating results and liquidity. These forward-looking statements generally are identified by words including, but not limited to, “anticipate,” “believe,” “estimate,” “continue,” “intend,” “expect,” “plan,” “forecast,” “project,” and similar expressions, or future-tense or conditional constructions such as “will,” “may,” “should,” “could,” etc. The Company cautions that these statements are merely predictions and are not to be considered guarantees of future performance. Forward-looking statements are based upon current expectations and assumptions that are subject to risks and uncertainties that can cause actual results to differ materially from those projected, anticipated, or implied.

A detailed discussion of potential risks and uncertainties that could cause actual results and events to differ materially from forward-looking statements is included in Part I, Item 1A — “Risk Factors” of the Annual Report on Form 10-K for the year ended December 31, 2018 (“Annual Report”) and periodically in subsequent reports filed with the Securities and Exchange Commission (“SEC”). The Company has no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the unaudited condensed consolidated financial statements and the related notes thereto of this Quarterly Report, as well as the Annual Report. Phrases such as “Company,” “we,” “our,” and “us” refer to Flotek Industries, Inc. and its subsidiaries.

### Basis of Presentation

During the fourth quarter of 2018, the Company classified the Consumer and Industrial Chemistry Technologies segment as held for sale based on management’s intention to sell this business. The Company’s historical financial statements have been revised to present the operating results of the Consumer and Industrial Chemistry Technologies segment as discontinued operations. The results of operations of this segment are presented as “Income from discontinued operations” in the statement of operations and the related cash flows of this segment have been reclassified to discontinued operations for all periods presented. The assets and liabilities of the Consumer and Industrial Chemistry Technologies segment have been reclassified to “Assets held for sale” and “Liabilities held for sale,” respectively, in the consolidated balance sheets for all periods presented. During the first quarter of 2019, the Company completed the sale of this segment.

### Executive Summary

Flotek is an international energy chemistry technology-driven company that develops and supplies chemistries and services to the oil and gas industry. Through February 28, 2019, Flotek also provided high value compounds to companies that make food and beverages, cleaning products, cosmetics, and other products that are sold in consumer and industrial markets. Flotek operates in over 15 domestic and international markets.

The Company’s oilfield business includes specialty chemistries and logistics which enable its customers to pursue improved efficiencies in the drilling and completion of their wells. Customers include major integrated oil and gas (“O&G”) companies, oilfield services companies, independent O&G companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies. Through February 28, 2019, the Company also produced non-energy-related citrus oil and related products, classified as discontinued operations, including (1) high value compounds used as additives by companies in the flavors and fragrances markets and (2) environmentally friendly chemistries for use in numerous industries around the world, including the O&G industry. Additionally, the Company also provides automated bulk material handling, loading facilities, and blending capabilities.

### Continuing Operations

The operations of the Company are categorized into one reportable segment: Energy Chemistry Technologies (“ECT”).

Energy Chemistry Technologies designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas (“O&G”) well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Flotek’s specialty chemistries possess enhanced performance characteristics and are manufactured to perform in a broad range of basins and reservoirs with varying downhole pressures, temperatures and other well-specific conditions customized to customer specifications. This segment has technical services laboratories and a research and innovation laboratory that focus on design improvements, development and viability testing of new chemistry formulations, and continued enhancement of existing products.

### Discontinued Operations

In the first quarter of 2019, the Consumer and Industrial Chemistry Technologies segment was sold and is classified as discontinued operations.

Consumer and Industrial Chemistry Technologies designed, developed, and manufactured products that are sold to companies in the flavor and fragrance industries and specialty chemical industry. These technologies are used by beverage and food companies, fragrance companies, and companies providing household and industrial cleaning products.

### Market Conditions

The Company’s success is sensitive to a number of factors, which include, but are not limited to, drilling and well completion activity, customer demand for its advanced technology products, market prices for raw materials, and governmental actions.

Drilling and well completion activity levels are influenced by a number of factors, including the number of rigs in operation and the geographical areas of rig activity. Additional factors that influence the level of drilling and well completion activity include:

- Historical, current, and anticipated future O&G prices,
- Federal, state, and local governmental actions that may encourage or discourage drilling activity,
- Customers’ strategies relative to capital funds allocations,
- Weather conditions, and
- Technological changes to drilling and completion methods and economics.

Historical North American drilling activity is reflected in “TABLE A” on the following page.

Customers’ demand for advanced technology products and services provided by the Company are dependent on their recognition of the value of:

- Chemistries that improve the economics of their O&G operations,
- Chemistries that meet the need of consumer product markets, and
- Chemistries that are economically viable, socially responsible, and ecologically sound.

Market prices for commodities, including citrus oils, which are a major raw material used by the Company in its operations, can be influenced by:

- Historical, current, and anticipated future production levels of the global citrus (primarily orange) crops,
- Weather related risks,
- Health and condition of citrus trees (e.g., disease and pests), and
- International competition and pricing pressures resulting from natural and artificial pricing influences.

Governmental actions may restrict the future use of hazardous chemicals, including, but not limited to, the following industrial applications:

- O&G drilling and completion operations,
- O&G production operations, and
- Non-O&G industrial solvents.

| TABLE A Average North American Active Drilling Rigs | Three months ended September 30, 2019 | 2018 | % Change | Nine months ended September 30, 2019 | 2018 | % Change |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| U.S. | 920 | 1,051 | (12.5)% | 985 | 1,019 | (3.3)% |
| Canada | 132 | 209 | (36.8)% | 132 | 195 | (32.3)% |
| Total | 1,052 | 1,260 | (16.5)% | 1,117 | 1,214 | (8.0)% |
| Average U.S. Active Drilling Rigs by Type |  |  |  |  |  |  |
| Vertical | 52 | 63 | (17.5)% | 55 | 61 | (9.8)% |
| Horizontal | 802 | 921 | (12.9)% | 863 | 890 | (3.0)% |
| Directional | 66 | 67 | (1.5)% | 67 | 68 | (1.5)% |
| Total | 920 | 1,051 | (12.5)% | 985 | 1,019 | (3.3)% |
| Average North American Drilling Rigs by Product |  |  |  |  |  |  |
| Oil | 847 | 1,004 | (15.6)% | 884 | 954 | (7.3)% |
| Natural Gas | 205 | 256 | (19.9)% | 233 | 260 | (10.4)% |
| Total | 1,052 | 1,260 | (16.5)% | 1,117 | 1,214 | (8.0)% |

Source: Rig counts are per Baker Hughes, Inc. (www.bakerhughes.com). Rig counts are the averages of the weekly rig count activity.

Completions are per the U.S. Energy Information Administration (https://www.eia.gov/petroleum/drilling/) as of October 15, 2019.

Average U.S. rig activity decreased by 12.5% and 3.3% for the three and nine months ended September 30, 2019, respectively, when compared to the same periods of 2018, and sequentially, decreased by 7.0% when compared to the second quarter of 2019.

According to data collected by the U.S. Energy Information Administration (“EIA”) as reported on October 15, 2019, completions in the seven most prolific areas in the lower 48 states increased 10.1% and 11.8% for the three and nine months ended September 30, 2019, respectively, when compared to the same periods of 2018. Completions increased 0.3% when compared to the second quarter of 2019.

### Company Outlook

After a continuous decline in U.S. drilling activity beginning in mid-2014, the market began to gradually recover in the second quarter of 2016. Although O&G markets have improved, the level of drilling and completion activity remains lower than previous levels experienced before the downturn in 2014. Assuming the price for crude oil remains relatively soft and regulatory impediments are limited, the Company expects continued volatility in global oilfield activity for the remainder of 2019.

During the third quarter of 2019, the Company continued to promote the efficacy of its Complex nano-Fluid® (“CnF®”) chemistries and its Prescriptive Chemistry Management® (“PCM®”) offering. Although quarter-to-quarter performance may vary, the Company expects to continue to penetrate the market over time by demonstrating the efficacy of its CnF® chemistries and reservoir-centric full fluid systems via PCM®. The Company will continue to demonstrate the value and benefit of Flotek chemistries through comparative analysis of wells with and without Flotek chemistries and field validation results conducted in partnership with exploration and production (“E&P”) companies. Flotek is experiencing a notable shift in purchasing behaviors in which E&P companies are seeking greater transparency, control and efficacy in their fluid systems, as they see diminishing returns on mechanical factors in their completion designs, such as proppant loading, fluid loading, and lateral length in their completions. As a result, they are focusing more on sourcing consumables, including chemistry, directly from manufacturers and other providers of these products. This trend has created significant changes in Flotek’s customer base, product portfolio, and sales efforts and continues to influence changes in inventory and distribution strategies, capital allocation, and the business model for the Company. While these challenges are expected to persist in the near-term, the Company believes it can grow its client base and revenue opportunities over time.

The Company continues to enhance and improve its patented and proven chemistries through its industry leading research and innovation staff who develop innovative and customer- responsive products, as well as create new chemistry technologies, which are expected to address oilfield challenges of the future and expand the Company’s product lines. Completed in 2016, the Company’s Houston based Global Research & Innovation Center houses scientists, chemists, geologists, and reservoir, petroleum and geomechanical engineers who advance the development of next-generation innovative energy chemistries, as well as expanded collaboration among clients, leaders from academia, and Company scientists. These collaborative opportunities are an important and distinguishing capability within the industry and provide real-time product and fluid system development support directly to the customer.

During the fourth quarter of 2018, the Company initiated a strategic plan to sell its Consumer and Industrial Chemistry Technologies segment, which was completed in the first quarter of 2019. The Company continues to focus on maximizing the profitability of its product and business portfolio, and may exit or enter new product lines or businesses which complement its current operations.

Capital expenditures for continuing operations totaled $1.9 million and $3.8 million for the nine months ended September 30, 2019 and 2018, respectively. The Company expects capital expenditures to total approximately $2.2 million for 2019 and does not have any specific growth capital projects currently planned or committed. During the first quarter of 2019, the Company formed a Strategic Capital Committee that will consider these possible growth capital projects going forward. The Company will remain nimble in its core capital expenditure plans, adjusting as market conditions warrant, and will focus any growth capital spending program on uses that generate positive returns and to areas that pose a strategic long-term benefit.

During the first quarter and into the beginning of the second quarter of 2019, the Company lost several key sales personnel. In April 2019, the Company hired a new Senior Vice President of Global Sales & Business Development who now leads the Company’s domestic and international sales and business development strategies as well as operations. By the end of the third quarter, the Company had substantially rebuilt a more technically oriented sales organization; however, as a result of the transition of sales personnel, and the typically longer sales cycle for the company’s products, revenue for the remainder of 2019 may be negatively impacted. The Company believes the opportunity it has taken to enhance the technical background of its sales personnel together with relationships built with its customers, and the demonstrated value and benefit of Flotek’s chemistries will help to mitigate further potential revenue declines.

Changes to geopolitical, global economic, and industry trends could have an impact, either positive or negative, on the Company’s business. In the event of significant adverse changes to the demand for oil and gas production, the market price for oil and gas, weather patterns, and/or the availability of citrus crops, the market conditions affecting the Company could change rapidly and materially. Should such adverse changes to market conditions occur, management believes the Company has adequate liquidity to withstand the impact of such changes while continuing to make strategic capital investments and acquisitions, if opportunities arise. In addition, management believes the Company is well-positioned to take advantage of significant increases in demand for its products should market conditions improve dramatically in the near term.

### Results of Continuing Operations (in thousands):

|  | Three months ended September 30, 2019 | 2018 | Nine months ended September 30, 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $21,879 | $53,709 | $99,827 | $134,324 |
| Operating expenses (excluding depreciation and amortization) | 23,689 | 45,647 | 106,593 | 117,848 |
| Operating expenses % | 108.3% | 85.0% | 106.8% | 87.7% |
| Corporate general and administrative | 5,685 | 7,476 | 19,020 | 24,634 |
| Corporate general and administrative % | 26.0% | 13.9% | 19.1% | 18.3% |
| Depreciation and amortization | 2,058 | 2,259 | 6,437 | 6,935 |
| Research and development costs | 2,297 | 2,350 | 6,657 | 8,054 |
| Loss on disposal of long-lived assets | 3 | 57 | 1,096 | 119 |
| Impairment of goodwill | — | — | — | 37,180 |
| Loss from operations | (11,853) | (4,080) | (39,976) | (60,446) |
| Operating margin % | (54.2)% | (7.6)% | (40.0)% | (45.0)% |
| Loss on sale of business | — | (360) | — | (360) |
| Loss on write-down of assets held for sale | — | — | — | (2,580) |
| Interest and other income (expense), net | 435 | (736) | (778) | (4,501) |
| Loss before income taxes | (11,418) | (5,176) | (40,754) | (67,887) |
| Income tax benefit (expense) | 191 | 333 | 1,157 | (15,545) |
| Loss from continuing operations | (11,227) | (4,843) | (39,597) | (83,432) |
| Income from discontinued operations, net of tax | 117 | 911 | 46,881 | 4,176 |
| Net income (loss) | $(11,110) | $(3,932) | $7,284 | $(79,256) |
| Net (loss) income % | (51.3)% | (9.0)% | (39.7)% | (62.1)% |
| Net loss attributable to noncontrolling interests | — | — | — | 357 |
| Net income (loss) attributable to Flotek Industries, Inc. (Flotek) | $(11,110) | $(3,932) | $7,284 | $(78,899) |

### Consolidated Results of Operations: Three and Nine Months Ended September 30, 2019, Compared to the Three and Nine Months Ended September 30, 2018

Consolidated revenue for the three and nine months ended September 30, 2019, decreased $31.8 million, or 59.3%, and $34.5 million, or 25.7%, respectively, versus the same periods of 2018. The decrease in revenue was a result of the continued volatile macro-environment for U.S. onshore drilling and completion activity, the transition of personnel in the Company’s sales organization, and the deferral of completion activity by certain clients.

Consolidated operating expenses (excluding depreciation and amortization) for the three and nine months ended September 30, 2019, decreased $22.0 million, or 48.1%, and $11.3 million, or 9.6%, respectively, compared to the same periods of 2018, and, as a percentage of revenue, increased to 108.3% and 106.8%, for the three and nine months ended September 30, 2019, respectively from 85.0% and 87.7% in the same periods of 2018. The decrease is primarily due to lower material costs, lower logistics, lower labor, and lower inventory adjustments.

Corporate general and administrative (“CG&A”) expenses are not directly attributable to products sold or services provided. CG&A costs decreased $1.8 million, or 24.0%, and $5.6 million, or 22.8%, respectively, for the three and nine months ended September 30, 2019, versus the same periods of 2018. As a percentage of revenue, CG&A increased 12.1% and 0.7% for the three and nine months ended September 30, 2019, respectively. The decrease in CG&A costs were primarily due to lower personnel costs, lower software licensing fees and lower professional fees.

Depreciation and amortization expense decreased $0.2 million, or 8.9%, and $0.5 million, or 7.2%, for the three and nine months ended September 30, 2019, respectively versus the same periods of 2018.

Research and Innovation (“R&I”) expense decreased $0.1 million, or 2.3%, and $1.4 million, or 17.3%, for the three and nine months ended September 30, 2019, respectively, compared to the same periods of 2018. The decrease is primarily due to lower personnel costs related to the reductions in headcount associated costs savings initiatives during the first half of 2019.

Loss on disposal of long-lived assets remained flat for the three months ended September 30, 2019 but increased $1.0 million for the nine months ended September 30, 2019, compared to the same periods of 2018, primarily due to the disposal of certain corporate software in the first quarter of 2019.

Interest and other expense decreased $1.2 million and $3.7 million for the three and nine months ended September 30, 2019, respectively, versus the same periods of 2018, primarily due to a $1.2 million write-off associated with the discontinuation of certain corporate projects during the second quarter 2018 and $1.3 million related to moving from an interest expense position to an interest income position as a result of the sale of the CICT segment and subsequent termination of the Amended and Restated Revolving Credit, Term Loan and Security Agreement (as amended, the “Credit Facility”) with PNC Bank in the first quarter 2019. The decrease is partially offset by the acceleration of $1.4 million of unamortized debt issuance costs associated with the termination of the Credit Facility in the first quarter 2019.

The Company recorded an income tax benefit of $0.2 million and $1.2 million, yielding an effective tax benefit rate of 1.6% and 2.8%, for the three and nine months ended September 30, 2019, respectively, compared to an income tax benefit of $0.3 million and income tax expense of $15.5 million, yielding an effective tax benefit rate of 6.0% and 22.8%, for the comparable periods in 2018.

During the fourth quarter of 2018, the Company initiated a strategic plan to sell its Consumer and Industrial Chemistry Technologies segment, which was completed in the first quarter of 2019. The Company recorded net income from discontinued operations of $0.1 million and $46.9 million for the three and nine months ended September 30, 2019, respectively.

### Results by Segment

*(dollars in thousands)*

| Energy Chemistry Technologies (“ECT”) | Three months ended September 30, 2019 | 2018 | Nine months ended September 30, 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $21,879 | $53,709 | $99,827 | $134,324 |
| Income (loss) from operations | (5,984) | 3,921 | (18,968) | (34,176) |
| Income (loss) from operations - excluding impairment | (5,984) | 41,101 | (18,968) | 3,004 |
| Operating margin % | (27.4)% | 7.3% | (19.0)% | (25.4)% |

### ECT Results of Operations: Three and Nine Months Ended September 30, 2019, Compared to the Three and Nine Months Ended September 30, 2018

ECT revenue for the three and nine months ended September 30, 2019, decreased $31.8 million, or 59.3%, and $34.5 million, or 25.7%, respectively, and versus the same period of 2018. The decrease in revenue was a result of the continued volatile macro-environment for U.S. onshore drilling and completion activity, the transition of personnel in the Company’s sales organization, and the deferral of completion activity by certain clients.

The change in income (loss) from operations was unfavorable for the ECT segment by $9.9 million and favorable by $15.2 million for the three and nine months ended September 30, 2019, respectively, versus the same period in 2018. The unfavorability for the three months ended September 30, 2019 is primarily the result of lower sales volumes and lower plant utilization, partially offset by lower logistics and personnel costs. The favorability for the nine months ended September 30, 2019 is due to a non-recurring impairment of goodwill of $37.2 million in 2018 and lower personnel costs, partially offset by lower sales volumes and lower plant utilization.

### Discontinued Operations

During the fourth quarter of 2018, the Company classified the Consumer and Industrial Chemistry Technologies segment as held for sale based on management’s intention to sell the business. During the first quarter of 2019, the Company completed the sale of the segment. The Company’s historical financial statements have been revised to present the operating results of the Consumer and Industrial Chemistry Technologies segment as discontinued operations. The information below is presented for informational purposes only.

*(dollars in thousands)*

| Consumer and Industrial Chemistry Technologies (“CICT”) | Three months ended September 30, 2019 | 2018 | Nine months ended September 30, 2019 | 2018 |
| --- | ---: | ---: | ---: | ---: |
| Revenue | $— | $17,280 | $11,031 | $56,267 |
| Income (loss) from operations | — | 858 | (610) | 3,938 |
| Operating margin % | —% | 5.0% | (5.5)% | 7.0% |

### Off-Balance Sheet Arrangements

There have been no transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as “structured finance” or “special purpose entities” (“SPEs”), established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of September 30, 2019, the Company was not involved in any unconsolidated SPEs.

The Company has not made any guarantees to customers or vendors nor does the Company have any off-balance sheet arrangements or commitments that have, or are reasonably likely to have, a current or future effect on the Company’s financial condition, change in financial condition, revenue, expenses, results of operations, liquidity, capital expenditures, or capital resources that would be material to investors other than the long term terpene agreement discussed in Note 3.

### Critical Accounting Policies and Estimates

The Company’s Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Preparation of these statements requires management to make judgments, estimates, and assumptions that affect the amounts reported in the financial statements and accompanying footnotes. Part II, Item 8 — Financial Statements and Supplementary Data, Note 2 of “Notes to Consolidated Financial Statements” and Part II, Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations, “Critical Accounting Policies and Estimates” of the Company’s Annual Report, and the “Notes to Unaudited Condensed Consolidated Financial Statements” of this Quarterly Report describe the significant accounting policies and critical accounting estimates used to prepare the consolidated financial statements. Critical accounting policies and estimates are defined as those that are both most important to the portrayal of the Company’s financial condition and results of operations and require management’s most subjective judgments. The Company regularly reviews and challenges judgments, assumptions, and estimates related to critical accounting policies. The Company’s estimates and assumptions are based on historical experience and expected changes in the business environment; however, actual results may materially differ from the estimates. There have been no significant changes in the Company’s critical accounting estimates during the nine months ended September 30, 2019.

### Recent Accounting Pronouncements

Recent accounting pronouncements which may impact the Company are described in Note 2 — “Recent Accounting Pronouncements” in Part I, Item 1 — “Financial Statements” of this Quarterly Report.

### Capital Resources and Liquidity

### Overview

The Company’s ongoing capital requirements arise from the Company’s need to acquire and maintain equipment, fund working capital requirements, and when the opportunities arise, to make strategic acquisitions and repurchase Company stock. During the first nine months of 2019, the Company funded capital requirements primarily with cash on hand, including proceeds from the sale of the CICT segment, and debt financing.

Historically, the Company’s primary source of debt financing was its $75 million Credit Facility with PNC Bank. Upon closing of the sale of the CICT segment, on March 1, 2019, the Company repaid the outstanding balance, interest, and fees related to the revolving credit facility, and subsequently terminated the Credit Facility. Significant terms of the Credit Facility are discussed in Note 13 — “Long-Term Debt and Credit Facility” in Part II, Item 8 — “Financial Statements and Supplementary Data” of the Company’s Annual Report.

The Company believes it has adequate liquidity to fund its ongoing operations and capital expenditures. As of September 30, 2019, the Company had available cash and cash equivalents of $107.0 million. For the remainder of 2019, the Company expects maintenance capital spending of approximately $0.3 million and does not have any specific growth capital projects currently planned or committed. Futhermore, the Company plans to use internally generated funds and cash on hand to fund operations and capital expenditures. With the proceeds from the sale of the CICT segment, the Company paid off its Credit Facility balance and formed a Strategic Capital Committee to evaluate and make recommendations to the board of directors regarding the manner in which the remaining net proceeds from the sale will be deployed. Subject to Board approval of any recommendations by the Strategic Capital Committee, the Company will continue to invest capital in what it believes to be economically attractive opportunities for its shareholders. This includes the potential for share repurchases included under our share repurchase program approved by the board of directors in June 2015.

Any excess cash generated may be used for outside growth opportunities or retained for future use.

### Cash Flows

Consolidated cash flows by type of activity are noted below (in thousands):

|  | Nine months ended September 30, 2019 | 2018 |
| --- | ---: | ---: |
| Net cash used in operating activities | $(13,685) | $(24,781) |
| Net cash (used in) provided by investing activities | 167,497 | (3,405) |
| Net cash (used in) provided by financing activities | (49,880) | 25,247 |
| Net cash flows provided by discontinued operations | 16 | 250 |
| Effect of changes in exchange rates on cash and cash equivalents | 2 | (66) |
| Net increase (decrease) in cash and cash equivalents | $103,950 | $(2,755) |

#### Operating Activities

Net cash used in operating activities was $13.7 million and $24.8 million during the nine months ended September 30, 2019 and 2018, respectively. Consolidated net loss for the nine months ended September 30, 2019 and 2018, totaled $39.6 million and $83.4 million, respectively.

During the nine months ended September 30, 2019, net non-cash contributions to net income totaled $31.0 million. Contributory non-cash items consisted primarily of $18.0 million for changes to deferred income taxes driven by the valuation allowance recorded against deferred tax assets, $7.9 million for depreciation and amortization, $2.8 million for stock compensation expense, and $1.1 million for net loss on disposal of long-lived assets.

During the nine months ended September 30, 2018, net non-cash contributions to net income totaled $71.7 million. Contributory non-cash items consisted primarily of $37.2 million for the goodwill impairment charge, $15.4 million for changes to deferred income taxes driven by the valuation allowance recorded against deferred tax assets, $6.6 million for stock compensation expense, loss on write-down of assets held for sale of $2.5 million, $7.2 million for depreciation and amortization and $1.8 million for provisions related to inventory reserves.

During the nine months ended September 30, 2019, changes in working capital used $5.1 million in cash, primarily resulting from increasing restricted cash and other current assets by $15.6 million and decreasing accounts payable, accrued liabilities and interest payable $17.6 million, partially offset by decreasing accounts receivable, inventories and income tax receivable by $27.5 million and increasing income tax payable by $0.6 million.

During the nine months ended September 30, 2018, changes in working capital used $13.4 million in cash, primarily resulting from increasing accounts receivable and inventory by $11.9 million and decreasing accrued liabilities and interest payable by $9.0 million, partially offset by increasing income tax receivable and other current assets by $1.8 million and increasing accounts payable by $5.6 million.

#### Investing Activities

Net cash provided by investing activities was $167.5 million for the nine months ended September 30, 2019. Cash provided by investing activities primarily included $169.7 million of proceeds received from the sale of the CICT segment, partially offset by $1.9 million for capital expenditures and $0.5 million for the purchase of various patents and intangible assets.

Net cash used in investing activities was $3.4 million for the nine months ended September 30, 2018. Cash used in investing activities primarily included $4.0 million for capital expenditures and $1.5 million for the purchase of various patents, partially offset by $0.4 million of proceeds received from the sale of long-lived assets and $1.6 million of proceeds from sale of business.

#### Financing Activities

Net cash used in financing activities was $49.9 million for the nine months ended September 30, 2019, due to using $49.7 million for repayments of debt, net of borrowings, associated with the termination of the Credit Facility and $0.2 million for purchases of treasury stock for tax withholding purposes related to the vesting of restricted stock awards.

Net cash generated through financing activities was $25.2 million for the nine months ended September 30, 2018, primarily due to receiving $25.5 million for borrowings of debt, net of repayments, and receiving $0.3 million in proceeds from the sale of common stock, partially offset by a loss from noncontrolling interest of $0.4 million and $0.2 million related to debt issuance costs and purchase of treasury stock.

### Contractual Obligations

Cash flows from operations are dependent on a variety of factors, including fluctuations in operating results, accounts receivable collections, inventory management, and the timing of payments for goods and services. Correspondingly, the impact of contractual obligations on the Company’s liquidity and capital resources in future periods is analyzed in conjunction with such factors.

Material contractual obligations consist of payments of finance and operating lease obligations. Contractual obligations at September 30, 2019, are as follows (in thousands):

|  | Payments Due by Period Total | Less than 1 year | 1 - 3 years | 3 - 5 years | More than 5 years |
| --- | ---: | ---: | ---: | ---: | ---: |
| Finance lease obligations | 260 | 70 | 109 | 78 | 3 |
| Operating lease obligations | 36,261 | 2,450 | 4,615 | 4,331 | 24,865 |
| Supply commitments for raw materials | 72,020 | 18,005 | 54,015 | — | — |
| Total | $108,541 | $20,525 | $58,739 | $4,409 | $24,868 |

## Market risk

As filed, 287 characters.

The Company is exposed to market risk from changes in interest rates, commodity prices, and foreign currency exchange rates. There have been no material changes to the quantitative or qualitative disclosures about market risk set forth in Part II, Item 7A of the Company’s Annual Report.

## Controls and procedures

As filed, 1,958 characters.

### Evaluation of Disclosure Controls and Procedures

The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The Company’s disclosure controls and procedures are also designed to ensure such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance that control objectives are attained. The Company’s disclosure controls and procedures are designed to provide such reasonable assurance.

The Company’s management, with the participation of the principal executive and principal financial officers, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of September 30, 2019, as required by Rule 13a-15(e) of the Exchange Act. Based upon that evaluation, the principal executive and principal financial officers have concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2019.

### Changes in Internal Control Over Financial Reporting

There have been no changes in the Company’s system of internal control over financial reporting during the three months ended September 30, 2019, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

## Risk factors

As filed, 282 characters.

See Part I, Item 1A — “Risk Factors" of the Company’s 2018 Annual Report on Form 10-K and Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 for a detailed discussion of the Company’s risk factors. There have been no material changes to these risk factors.

Filed Nov 12, 2019.
Source: SEC EDGAR, the filing index for accession 0000928054-19-000095. Last ingested by Listed: Nov 14, 2026, 17:51 ET. No prices; not investment advice.
